Non-biological DMARD (Disease-Modifying Antirheumatic Drug)

This page covers all Non-biological DMARD (Disease-Modifying Antirheumatic Drug) drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting TNF-alpha, IL-6, JAK.

Targets

TNF-alpha, IL-6, JAK

Marketed (1)

• non-biological DMARDs · Hoffmann-La Roche · Immunology
  Non-biological DMARDs are small-molecule drugs that suppress the immune system by inhibiting intracellular signaling pathways to reduce inflammation and joint damage in autoimmune diseases.

Phase 2 pipeline (1)

• Biological DMARDs · Hoffmann-La Roche · Immunology
  Biological DMARDs work by targeting specific proteins involved in the immune response to reduce inflammation and slow disease progression.

Patent intelligence

• biological dmard patent landscape — aggregated cliff calendar, attackable patents, originator estates